Vnitr Lek 2021, 67(7):E13-E17 | DOI: 10.36290/vnl.2021.115

Amanita phalloides intoxication: mechanism of toxicity, clinical manifestations and therapeutic approaches

Eva Kieslichová
Klinika anesteziologie, resuscitace a intenzivní péče, Institut klinické a experimentální medicíny, Praha
1. lékařská fakulta Univerzity Karlovy, Praha

Ingestion of Amanita phalloides is the most common cause of fatal mushroom poisoning. The clinical picture of intoxication varies from mild subclinical manifestation to lethal fulminant course with the development of acute liver failure. Early diagnosis of Amanita phalloides poisoning is crucial for the outcome but i tis difficult because it is often mistaken as gastroenteritis or due to other mushroom poisoning. The diagnosis is based on the history of recent mushroom ingestion followed by gastrointestinal symptoms, typical time course and laboratory markers and is proven with mycological examination or toxicological examination. Specific treatment consists of detoxification procedures, supportive measures, administration of drugs and therapy in the specialized intensive care unit in the case of acute liver failure. In selected patients with acute liver failure urgent liver transplantation is the only life-saving option.

Keywords: acute liver failure, Amanita phalloides, intoxication, urgent liver transplantation.

Published: November 1, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kieslichová E. Amanita phalloides intoxication: mechanism of toxicity, clinical manifestations and therapeutic approaches. Vnitr Lek. 2021;67(7):E13-17. doi: 10.36290/vnl.2021.115.
Download citation

References

  1. Karlson‑Stiber C, Persson H. Cytotoxic fungi‑an overview. Toxicon, 2003; 42(4): 339-349. Go to original source... Go to PubMed...
  2. Diaz JH. Amatoxin‑Containing Mushroom Poisonings: Species, Toxidromes, Treatments, and Outcomes. Wilderness Environ Med 2018; 29(1): 111-118. Go to original source... Go to PubMed...
  3. Broussard CN, Aggarwal A, Lacey SR et al. Mushroom poisoning-from diarrhea to liver transplantation. Am J Gastroenterol, 2001; 96 (11): 3195-3198. Go to original source...
  4. Mas A. Mushrooms, amatoxins and the liver. J Hepatol, 2005; 42(2): 166-169. Go to original source... Go to PubMed...
  5. Ganzert M, Felgenhauer N, Zilker T. Indication of liver transplantation following amatoxin intoxication. J Hepatol, 2005; 42(2): 202-209. Go to original source... Go to PubMed...
  6. Escudie C. Francoz JP, Vine R et al. Amanita phalloides poisoning: reassessment of prognostic factors and indications for emergency liver transplantation. Journal of Hepatology, 2007; 46(3): 466-473. Go to original source... Go to PubMed...
  7. Himmelmann A, Mang G, Schnorf‑Huber S. Lethal ingestion of stored Amanita phalloides mushrooms. Swiss Med Wkly, 2001;131(41-42): 616-617. Go to original source... Go to PubMed...
  8. Garcia J, Costa VM, Carvalho A et al. Amanita phalloides poisoning: mechanisms of toxicity and treatment. Food Chem Toxicol, 2015; 86: 41-55. Go to original source... Go to PubMed...
  9. Le Darre B, Ferron PJ, Gicquel T. Toxic effects of amanitins: Repurposing toxicities toward new therapeutics. Toxins, 2021; 13(6): 417. Go to original source... Go to PubMed...
  10. Santi, L, Maggioli C, Mastroroberto M et al. Acute Liver Failure Caused by Amanita phalloides Poisoning. Int J Hepatol, 2012; 2012: 487-480. Go to original source... Go to PubMed...
  11. European Association for the Study of the Liver. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol, 2017; 66(5): 1047-1081. Go to original source... Go to PubMed...
  12. Montrief T, Koyfman A, Long B. Acute liver failure: A review for emergency physicians. Am J Emerg Med, 2019; 37(2): 329-337. Go to original source... Go to PubMed...
  13. Enjalbert F, Rapior S, Nouguier‑Soulé J et al. Treatment of amatoxin poisoning: 20-year retrospective analysis. J Toxicol Clin Toxicol, 2002; 40(6): 715-757. Go to original source... Go to PubMed...
  14. Ye Y, Liu Z. Management of Amanita phalloides poisoning: a literature review and update. J. Crit Care, 2018; 46: 17-22. Go to original source... Go to PubMed...
  15. Lacombe G. Towards evidence‑based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 1: Silibinin in suspected amatoxin‑containing mushroom poisoning. Emerg Med J, 2016; 33(1): 76-77. Go to original source... Go to PubMed...
  16. Ganzert M, Felgenhauer N, Schuster T et al. Amanita poisoning - comparison of silibinin with a combination of silibinin and penicillin. Dtsch Med Wochenschr, 2008; 133(4): 2261-67. Go to original source... Go to PubMed...
  17. Liu J, Chen Y, Gao Y, et al. N‑acetylcysteine as a treatment for amatoxin poisoning: a systematic review. Clin Toxicol (Phila), 2020; 58(11): 1015-1022. Go to original source... Go to PubMed...
  18. Mullins ME, Horowitz BZ. The futility of hemoperfusion and hemodialysis in Amanita phalloides poisoning. Vet Hum Toxicol, 2000; 42(2): 90-91.
  19. Jander S, Bischoff J, Woodcock BG. Plasmapheresis in the treatment of Amanita phalloides poisoning: II. A review and recommendations. Ther Apher, 2000; 4(4): 308-312. Go to original source... Go to PubMed...
  20. Karvellas CJ, Tillman H, Leung AA et al. United States Acute Liver Failure Study Group. Acute liver injury and acute liver failure from mushroom poisoning in North America. Liver Int, 2016; 36(7): 1043-1050. Go to original source... Go to PubMed...
  21. Seetharam A. Intensive care management of acute liver failure: Considerations while awaiting liver transplantation. J Clin Transl Hepatol, 2019; 7(4): 384-391. Go to original source... Go to PubMed...
  22. Kieslichová E, Fraňková S, Protuš M et al. Acute liver failure due to Amanita phalloides poisoning: therapeutic approach and outcome. Transplantation Proceedings 2018; 50(1): 192-197. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.